285 related articles for article (PubMed ID: 28235980)
1. Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure.
Lala RI; Lungeanu D; Darabantiu D; Pilat L; Puschita M
Herz; 2018 Mar; 43(2):146-155. PubMed ID: 28235980
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.
Lok DJ; Lok SI; Bruggink-André de la Porte PW; Badings E; Lipsic E; van Wijngaarden J; de Boer RA; van Veldhuisen DJ; van der Meer P
Clin Res Cardiol; 2013 Feb; 102(2):103-10. PubMed ID: 22886030
[TBL] [Abstract][Full Text] [Related]
3. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
[TBL] [Abstract][Full Text] [Related]
4. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Sluss P; Gaggin HK; Bhardwaj A; Januzzi JL
Eur J Heart Fail; 2013 Oct; 15(10):1157-63. PubMed ID: 23666680
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of a concentric left ventricular structure evaluated by transthoracic echocardiography in patients with acute decompensated heart failure: A retrospective study.
Yamaguchi S; Abe M; Arasaki O; Shimabukuro M; Ueda S
Int J Cardiol; 2019 Jul; 287():73-80. PubMed ID: 30158067
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
[TBL] [Abstract][Full Text] [Related]
7. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
[TBL] [Abstract][Full Text] [Related]
8. The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry.
Kim SH; Kim HJ; Han S; Yoo BS; Choi DJ; Kim JJ; Jeon ES; Cho MC; Chae SC; Ryu KH
PLoS One; 2017; 12(12):e0188938. PubMed ID: 29261675
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair.
Kortekaas KA; Hoogslag GE; de Boer RA; Dokter MM; Versteegh MI; Braun J; Marsan NA; Verwey HF; Delgado V; Schalij MJ; Klautz RJ
Eur J Heart Fail; 2013 Sep; 15(9):1011-8. PubMed ID: 23576289
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.
Tang WH; Shrestha K; Shao Z; Borowski AG; Troughton RW; Thomas JD; Klein AL
Am J Cardiol; 2011 Aug; 108(3):385-90. PubMed ID: 21600537
[TBL] [Abstract][Full Text] [Related]
11. Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
Fiuzat M; Schulte PJ; Felker M; Ahmad T; Neely M; Adams KF; Donahue MP; Kraus WE; Piña IL; Whellan DJ; O'Connor CM
J Card Fail; 2014 Jan; 20(1):38-44. PubMed ID: 24304938
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 in Patients with Acute Heart Failure: Preliminary Report on First Polish Experience.
Sygitowicz G; Tomaniak M; Filipiak KJ; Kołtowski Ł; Sitkiewicz D
Adv Clin Exp Med; 2016; 25(4):617-23. PubMed ID: 27629834
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.
van der Velde AR; Gullestad L; Ueland T; Aukrust P; Guo Y; Adourian A; Muntendam P; van Veldhuisen DJ; de Boer RA
Circ Heart Fail; 2013 Mar; 6(2):219-26. PubMed ID: 23395934
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction.
Carrasco-Sánchez FJ; Aramburu-Bodas O; Salamanca-Bautista P; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio MI; Arias-Jiménez JL; Aguayo-Canela M; Pérez-Calvo JI
Int J Cardiol; 2013 Nov; 169(3):177-82. PubMed ID: 24207066
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
[TBL] [Abstract][Full Text] [Related]
17. Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.
Bouwens E; Brankovic M; Mouthaan H; Baart S; Rizopoulos D; van Boven N; Caliskan K; Manintveld O; Germans T; van Ramshorst J; Umans V; Akkerhuis KM; Kardys I
J Am Heart Assoc; 2019 Feb; 8(4):e009555. PubMed ID: 30760105
[TBL] [Abstract][Full Text] [Related]
18. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
20. The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure.
Miró Ò; González de la Presa B; Herrero-Puente P; Fernández Bonifacio R; Möckel M; Mueller C; Casals G; Sandalinas S; Llorens P; Martín-Sánchez FJ; Jacob J; Bedini JL; Gil V
Biomarkers; 2017 Dec; 22(8):731-739. PubMed ID: 28406038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
